Salem Investment Counselors’s Sanara MedTech SMTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$239K Sell
10,134
-9,066
-47% -$187K 0.01% 384
2026
Q1
$330K Buy
19,200
+8,303
+76% +$171K 0.01% 329
2025
Q4
$254K Buy
10,897
+2,182
+25% +$56.3K 0.01% 349
2025
Q3
$277K Sell
8,715
-2,500
-22% -$75.5K 0.01% 339
2025
Q2
$318K Hold
11,215
0.01% 324
2025
Q1
$346K Hold
11,215
0.01% 295
2024
Q4
$372K Hold
11,215
0.01% 291
2024
Q3
$339K Hold
11,215
0.01% 307
2024
Q2
$316K Buy
11,215
+5
+0% +$157 0.01% 304
2024
Q1
$415K Hold
11,210
0.01% 284
2023
Q4
$461K Sell
11,210
-2,000
-15% -$64.2K 0.02% 261
2023
Q3
$411K Hold
13,210
0.02% 265
2023
Q2
$530K Hold
13,210
0.02% 232
2023
Q1
$545K Buy
13,210
+2,000
+18% +$84.3K 0.02% 231
2022
Q4
$510K Hold
11,210
0.02% 238
2022
Q3
$333K Hold
11,210
0.02% 267
2022
Q2
$234K Hold
11,210
0.01% 307
2022
Q1
$319K Hold
11,210
0.01% 294
2021
Q4
$331K Hold
11,210
0.01% 312
2021
Q3
$384K Hold
11,210
0.02% 273
2021
Q2
$414K Buy
11,210
+2,202
+24% +$64.4K 0.02% 258
2021
Q1
$281K Buy
+9,008
New +$312K 0.02% 257

Other funds holding SMTI

Salem Investment Counselors's SMTI Position: Q2 2026 in Review

Salem Investment Counselors reduced its Sanara MedTech (SMTI) stake by 47% in Q2 2026, selling an estimated $187K and leaving 10,134 shares worth $239K. The position accounts for 0.01% of the portfolio, ranked #384.

Salem Investment Counselors first reported a position in SMTI in Q1 2021 and has held it in 22 quarters since. The position peaked at $545K in Q1 2023. 20 funds tracked by Wall St. Rank hold SMTI as of Q2 2026.

  • Salem Investment Counselors held 10,134 shares of Sanara MedTech worth $239K as of Q2 2026.
  • Salem Investment Counselors sold 9,066 Sanara MedTech shares in Q2 2026, an estimated $187K.
  • Sanara MedTech made up 0.01% of Salem Investment Counselors's portfolio in Q2 2026, its #384 holding.
  • Salem Investment Counselors first reported a position in Sanara MedTech in Q1 2021 and has held it in 22 quarters since.
  • Salem Investment Counselors's Sanara MedTech position peaked at $545K in Q1 2023.
  • 20 funds tracked by Wall St. Rank held Sanara MedTech as of Q2 2026.

Based on Salem Investment Counselors's 13F filing for Q2 2026, filed 14 Jul 2026.